| Cardiac non‐Hodgkin's lymphoma: clinical characteristics and trends in survival MJ Gordon, O Danilova, S Spurgeon, AV Danilov European journal of haematology 97 (5), 445-452, 2016 | 88 | 2016 |
| Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib MJ Gordon, M Churnetski, H Alqahtani, X Rivera, A Kittai, SM Amrock, ... Cancer 124 (15), 3192-3200, 2018 | 82 | 2018 |
| Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy IB Greenwell, AD Staton, MJ Lee, JM Switchenko, DF Saxe, JJ Maly, ... Cancer 124 (11), 2306-2315, 2018 | 56 | 2018 |
| Comorbidities predict inferior survival in patients receiving chimeric antigen receptor T cell therapy for diffuse large B cell lymphoma: a multicenter analysis AS Kittai, Y Huang, M Gordon, N Denlinger, A Mian, L Fitzgerald, J Bishop, ... Transplantation and Cellular Therapy 27 (1), 46-52, 2021 | 51 | 2021 |
| The chronic lymphocytic leukemia comorbidity index (CLL-CI): a three-factor comorbidity model MJ Gordon, A Kaempf, A Sitlinger, G Shouse, M Mei, DM Brander, ... Clinical Cancer Research 27 (17), 4814-4824, 2021 | 39 | 2021 |
| Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study AS Zayac, AM Evens, A Danilov, SD Smith, D Jagadeesh, LA Leslie, ... Haematologica 106 (7), 1932, 2021 | 34 | 2021 |
| Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia. MJ Gordon, PW Raess, K Young, SEF Spurgeon, AV Danilov British Journal of Haematology 179 (3), 2017 | 33 | 2017 |
| Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy DA Bond, JM Switchenko, D Villa, K Maddocks, M Churnetski, AS Gerrie, ... Blood advances 5 (23), 5179-5189, 2021 | 31 | 2021 |
| A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma G Shouse, A Kaempf, MJ Gordon, A Artz, D Yashar, AM Sigmund, ... Blood Advances 7 (14), 3516-3529, 2023 | 29 | 2023 |
| Follicular lymphoma: The long and winding road leading to your cure? MJ Gordon, MR Smith, LJ Nastoupil Blood Reviews 57, 100992, 2023 | 29 | 2023 |
| CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation MJ Gordon, P Tardi, MM Loriaux, SE Spurgeon, E Traer, T Kovacsovics, ... Leukemia Research 53, 39-49, 2017 | 26 | 2017 |
| The effect of implant design on sagittal plane stability: a randomized trial of medial-versus posterior-stabilized total knee arthroplasty AI Edelstein, S Bhatt, J Wright-Chisem, R Sullivan, M Beal, DW Manning The Journal of Knee Surgery 33 (05), 452-458, 2020 | 25 | 2020 |
| Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials MJ Gordon, J Huang, RJ Chan, P Bhargava, AV Danilov British journal of haematology 192 (4), 720-728, 2021 | 22 | 2021 |
| The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia MJ Gordon, AV Danilov Therapeutic Advances in Hematology 12, 2040620721989588, 2021 | 22 | 2021 |
| Multi‐center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era R Karmali, JM Switchenko, S Goyal, K Shanmugasundaram, ... American journal of hematology 96 (11), 1374-1384, 2021 | 19 | 2021 |
| The CLL comorbidity index in a population-based cohort: a tool for clinical care and research EC Rotbain, MJ Gordon, N Vainer, H Frederiksen, H Hjalgrim, AV Danilov, ... Blood advances 6 (8), 2701-2706, 2022 | 18 | 2022 |
| Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer JN Graff, MJ Gordon, TM Beer Expert opinion on pharmacotherapy 16 (5), 749-754, 2015 | 17 | 2015 |
| Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma O Calzada, JM Switchenko, JJ Maly, KA Blum, N Grover, S Mathews, ... Leukemia & lymphoma 59 (12), 2862-2870, 2018 | 16 | 2018 |
| Monograph series on aging related diseases: Osteoporosis M Gordon, J Huang Chronic Diseases in Canada 16 (1), 1-23, 1995 | 16 | 1995 |
| Maintenance rituximab improves outcomes in mantle cell lymphoma patients who respond to induction therapy with bendamustine+ rituximab without autologous transplant BT Hill, JM Switchenko, P Martin, MC Churnetski, Y Sawalha, S Goyal, ... Blood 134, 1525, 2019 | 15 | 2019 |
